Medications

Addition of maintenance olaparib slows advanced ovarian cancer

(HealthDay)—Compared with placebo, the addition of olaparib to maintenance therapy with bevacizumab is associated with a significant progression-free survival benefit for patients with advanced ovarian cancer, according ...

Oncology & Cancer

Care at high-volume facility may cut mortality in multiple myeloma

(HealthDay)—Patients with multiple myeloma (MM) may receive a survival benefit from being treated at high-volume facilities, according to a study published in the September issue of the Journal of the National Comprehensive ...

page 31 from 40